Celebrating Our First Anniversary on the Global Stage
In October 2023, SiBionics embarked on a new chapter, taking our first steps onto the global stage. We made our debut with global partners at the European Association for the Study of Diabetes (EASD) conference. Obtaining the CE mark marked our initial stride towards our mission of "serving a global audience."
- November brought another milestone—the launch of the SiBionics app on the App Store. This pivotal moment saw our first user sign up, marking the beginning of their journey with our CGM. This was the start of our "From 0 to 1" story.
- SiBionics quickly became the first choice for many, empowering individuals to manage their blood glucose for the first time. As more partners embraced the SiBionics vision, our global expansion continued to gain momentum.
- In January 2024, we began the year with a strong presence at Arab Health, followed by our Global Partner Summit in February, laying the foundation for a future built on collaboration and innovation. March marked another key moment with the SIBIONICS Influencer Talk at the Advanced Technologies & Treatments for Diabetes (ATTD) conference, where we connected with new friends, strengthened our community, and expanded our reach.
- In July, our participation in the AGP & DTx Conference further extended our influence in the global medical field, advancing our commitment to innovation and care. As we move forward, united by the light of technology, we are excited to roll out SiWatch—a new product that connects directly to our CGM, offering users more freedom and flexibility.
Our mission remains clear: to be the first brand of choice, creating quality products that empower lives.
Together, we continue the journey from 0 to 1.
Happy First Anniversary from all of us at SiBionics.